Drawing for COMPASS ONCOLOGY

USPTO serial 78828643

COMPASS ONCOLOGY

Reviewed by CopyMark Law Group

Reg. 3871637Status 800Registered
Filing date
Status date
Registration date
Nov 2, 2010
Examiner
HELFMAN, JUDITH MICHELLE
Law office
GENERIC WEB UPDATE

What this means

Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with COMPASS ONCOLOGY?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Claire F. Hawkins

Claire F. Hawkins FOSTER GARVEY P.C.1111 THIRD AVENUE, SUITE 3000SEATTLE, WA 98101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Managing the operations of ambulatory infusion centers, digital imaging centers, specialty care facilities, and medical imaging centers; database management of databases available to others for database retrieval, data query, data aggregation, and data analysis in the field of oncology; providing sales and marketing data and data analysis to third-party manufacturers and suppliers of pharmaceutical products and health care products and supplies; providing utilization review services to managed care organizations, at-risk providers, HMOs, employers, and health insurance plans by applying treatment guidelines to the course of treatment proposed by providers for specific patients with cancer or chronic diseases; providing database management concerning cost, frequency of procedures, prescriptions, and providers' behavior in the field of cancer and care management; providing database collection of business information concerning cost, frequency of procedures, prescriptions, and providers' behavior concerning cancer and care management medical practices; business consulting services in the fields of medical practice managementACTIVEJul 1, 2007
042Conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research; technical and scientific data analysis in the field of oncology; providing general medical legal information in the form of legal descriptions of customary standards of care of medical practice; scientific and research consulting services, namely, technical data collection, research analysis and technical reporting of patients' outcomes and resulting prescribing data in the field of oncologyACTIVEJul 1, 2007
044Health care services, namely, home administration and in-home infusion of prescription drugs in the nature of home medical care; disease management services, namely, providing cancer and care management information, analysis and guidelines to patients, their families, care providers, managed care organizations, employers, clinical research organizations, at-risk providers, pharmaceutical entities, health maintenance organizations and health insurance plans; providing information to others regarding cancer and care management, medical conditions, information regarding available treatments for chronic cancer and information in the form of aggregated data for the purpose of assisting with medical analyses of medical outcomes; providing wellness, clinical health and practical medical information for chronically ill patients and their families; providing cancer care management programs; medically based data aggregation services, namely, aggregation of medical data from multiple databases and other resources in the field of oncology; medical data analysis in the field of oncology; providing medical databases in the field of oncology specifically containing outcome data, pharmaceutical and prescription information, physician referral information, insurance information, medical history information and related rules that pertain to the processing of such dataACTIVEJul 1, 2007

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jan 25, 2021NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED—
Jan 25, 2021RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Jan 25, 202189AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 25, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Nov 2, 2020E89RTEAS SECTION 8 & 9 RECEIVED—
Dec 18, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 18, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 2, 2019REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Mar 7, 2016NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Mar 7, 2016C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Mar 7, 2016APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 5, 2016E815TEAS SECTION 8 & 15 RECEIVED—
Nov 2, 2015REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 8, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 1, 2011ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Nov 2, 2010R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 29, 2010SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Sep 28, 2010REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Sep 26, 2010CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Sep 25, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 24, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 24, 2010ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Aug 22, 2010GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 22, 2010GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 22, 2010CNFRSU - FINAL REFUSAL - WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 27, 2010TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 27, 2010CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 27, 2010ALIEASSIGNED TO LIE—
Jul 15, 2010TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 27, 2010GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2010GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 27, 2010CNRTSU - NON-FINAL ACTION - WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 26, 2010SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Feb 1, 2010EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jan 30, 2010IUAFUSE AMENDMENT FILED—
Dec 14, 2009TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 27, 2009EX5GSOU EXTENSION 5 GRANTED—
Aug 25, 2009AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jul 24, 2009EXT5SOU EXTENSION 5 FILED—
Jul 24, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 26, 2009EX4GSOU EXTENSION 4 GRANTED—
Jan 26, 2009EXT4SOU EXTENSION 4 FILED—
Jan 26, 2009EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 26, 2008EX3GSOU EXTENSION 3 GRANTED—
Jun 26, 2008EXT3SOU EXTENSION 3 FILED—
Jun 26, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 25, 2008EX2GSOU EXTENSION 2 GRANTED—
Jan 28, 2008EXT2SOU EXTENSION 2 FILED—
Jan 28, 2008EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jul 18, 2007EX1GSOU EXTENSION 1 GRANTED—
Jul 18, 2007EXT1SOU EXTENSION 1 FILED—
Jul 18, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 30, 2007NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 7, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 18, 2006NPUBNOTICE OF PUBLICATION—
Sep 18, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Sep 15, 2006ALIEASSIGNED TO LIE—
Sep 12, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2006XAECEXAMINER'S AMENDMENT ENTERED—
Sep 12, 2006GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 12, 2006CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 21, 2006DOCKASSIGNED TO EXAMINER—
Mar 9, 2006NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance